Apricot Capital
29
15M
22
3.22
8
0.03
2
- Areas of investment
Summary
In 2010 was created Apricot Capital, which is appeared as VC. The venture was found in North America in United States. The main department of described VC is located in the Boston.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Apricot Capital, startups are often financed by Versant Ventures, Tavistock Life Sciences, 5AM Ventures. The meaningful sponsors for the fund in investment in the same round are Zhongjin Qichen, Where Angels Fund, Walter Winshall. In the next rounds fund is usually obtained by Romulus Capital, SeedInvest, New Enterprise Associates.
The overall number of key employees were 2.
Speaking about the real fund results, this VC is 10 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2019. The top amount of exits for fund were in 2014. Comparing to the other companies, this Apricot Capital performs on 11 percentage points more the average number of lead investments.
The fund has specific favorite in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Education, Mobile. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Bellen, Placester, Ambrx For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 29
- Lead investments
- 8
- Exits
- 2
- Rounds per year
- 3.22
- Follow on index
- 0.03
- Investments by industry
- Biotechnology (11)
- Health Care (11)
- Medical (7)
- Manufacturing (7)
- Medical Device (7) Show 18 more
- Investments by region
-
- China (20)
- United States (3)
- Peak activity year
- 2019
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 68M
- Group Appearance index
- 0.79
- Avg. company exit year
- 18
- Strategy success index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| GensKey | 03 Nov 2020 | Health Care, Medical | Late Stage Venture | 35M | Beijing, Dongcheng District, China |
| Hepagene Therapeutics | 26 Apr 2021 | Early Stage Venture | 40M | Nanjing, Jiangsu, China | |
| Jan Medical | 17 Jun 2011 | Biotechnology, Health Care, Health Diagnostics, Medical | Early Stage Venture | 3M | United States, California, Mountain View |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.